跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CLINIMIX E - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
CLINIMIX E
Authorized
STANDARD
CLINIMIX E
baxter corporation
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8c5d90c6ddcade98
Company
baxter corporation
Type
Standard
Approval Details
Approval Id
8c5d90c6ddcade98
Drug Approval Canada Name
CLINIMIX E
Product Name
CLINIMIX E
Status
Marketed
Status Date
2021-10-01
Original Market Date
2021-10-01
Din
02498413
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:20.00
Atc Original
B05BA10 COMBINATIONS
Atc Name
b 05 ba 10
Aig Number
2062219002
Company Name
baxter corporation
Company Address
7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2
Active Ingredients
CALCIUM CHLORIDE
33 MG / 100 ML
ALANINE
1656 MG / 100 ML
DEXTROSE
10 G / 100 ML
GLYCINE
824 MG / 100 ML
L-LEUCINE
584 MG / 100 ML
L-ARGININE
920 MG / 100 ML
L-ISOLEUCINE
480 MG / 100 ML
L-LYSINE HYDROCHLORIDE
464 MG / 100 ML
L-PHENYLALANINE
448 MG / 100 ML
HISTIDINE
384 MG / 100 ML
L-PROLINE
544 MG / 100 ML
L-THREONINE
336 MG / 100 ML
L-VALINE
464 MG / 100 ML
METHIONINE
320 MG / 100 ML
L-TYROSINE
32 MG / 100 ML
POTASSIUM PHOSPHATE DIBASIC
261 MG / 100 ML
SERINE
400 MG / 100 ML
SODIUM CHLORIDE
205 MG / 100 ML
MAGNESIUM CHLORIDE
24 MG / 100 ML
TRYPTOPHAN
144 MG / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8c5d90c6ddcade98
Type
Standard
Back to Health Canada Approvals